Bertram Köhler
Directeur Général chez DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG
Profil
Bertram Köhler is currently the Chief Executive Officer & Director at Deutsche Effecten & Wechsel Beteiligungs AG since 2012.
He is also the Chief Executive Officer at DEWB AG (Venture Capital) since 2012.
Additionally, he holds the position of Director-Supervisory Board at NOXXON Pharma AG, Director at LemnaTec GmbH, Managing Director at DEWB Effecten GmbH, Chief Investment Officer at Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) since 2003, and Member-Supervisory Board at aifinyo AG since 2020.
Formerly, Mr. Köhler served as Vice Chairman-Supervisory Board at SMARTRAC TECHNOLOGY Dresden GmbH, Director at Integrated Genomics, Inc., Director at Nanotron Technologies GmbH, Director at DirectPhotonics Industries GmbH, and Member-Supervisory Board at 4Flow AG.
He was also a Member-Supervisory Board at TME Pharma NV from 2016 to 2021.
Postes actifs de Bertram Köhler
| Sociétés | Poste | Début |
|---|---|---|
| DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Directeur Général | 01/01/2012 |
| AIFINYO AG | Directeur/Membre du Conseil | 01/07/2020 |
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt)
 Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) Investment ManagersFinance Part of Deutsche Effecten & Wechsel Beteiligungs AG, Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) specializes in private equity fund. The company is based in Jena, Germany. | Directeur en chef des Investissements | 04/09/2003 |
DEWB AG (Venture Capital)
 DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Directeur Général | 01/01/2000 |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | 16/11/2009 |
LemnaTec GmbH
 LemnaTec GmbH Medical SpecialtiesHealth Technology LemnaTec GmbH develops research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology, and pharmacy. It generates reproducible and scientifically sound images in light wavelengths. The firm develops also imaging, image analysis automatisation, and data handling modules. The company was founded by Dirk Vandenhirtz and Matthias Eberius in 1998 and is headquartered in Aachen, Germany. | Directeur/Membre du Conseil | - |
DEWB Effecten GmbH
 DEWB Effecten GmbH Financial ConglomeratesFinance Part of Deutsche Effecten & Wechsel Beteiligungs AG, DEWB Effecten GmbH operates as an investment holding German company. The company is based in Jena, Germany. The CEO of the company is Bertram Köhler. | Directeur Général | - |
Anciens postes connus de Bertram Köhler
| Sociétés | Poste | Fin |
|---|---|---|
| TME PHARMA N.V. | Directeur/Membre du Conseil | 24/06/2021 |
Integrated Genomics, Inc.
 Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Directeur/Membre du Conseil | 10/06/2011 |
| ░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DEUTSCHE EFFECTEN- UND WECHSEL-BETEILIGUNGSGESELLSCHAFT AG | Finance |
| TME PHARMA N.V. | Health Technology |
| AIFINYO AG | Finance |
| Entreprise privées | 10 |
|---|---|
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt)
Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) Investment ManagersFinance Part of Deutsche Effecten & Wechsel Beteiligungs AG, Deutsche Effecten & Wechsel Beteil AG (Asset Mgmt) specializes in private equity fund. The company is based in Jena, Germany. | Finance |
DEWB AG (Venture Capital)
DEWB AG (Venture Capital) Investment ManagersFinance DEWB AG (Venture Capital) (DEWB-VC) is the venture capital subsidiary of Deutsche Effecten & Wechsel Beteiligungs AG (FR: EFF), headquartered in Jena, Germany. The firm, established in 1997, provides equity capital, corporate development expertise and network support to strong growth, medium-sized technology companies. | Finance |
4Flow AG
 4Flow AG Packaged SoftwareTechnology Services 4Flow AG offers consulting services and software in the field of logistics and supply chain management. It caters automotive manufacturers, suppliers, consumer goods and retail, renewable energy, telecommunications, medical technology, machinery manufacturers, basic materials industry, spare parts, packaging industry, logistics service providers (LSP) and small and medium businesses. The firm has offices in Belgium, Brazil, China, Czech Republic, Hungary and USA. The company was founded by Stefan Wolff and Kai Althoff in 2000 and is headquartered in Berlin, Germany. | Technology Services |
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
SMARTRAC TECHNOLOGY Dresden GmbH
 SMARTRAC TECHNOLOGY Dresden GmbH Electronic Production EquipmentElectronic Technology SMARTRAC TECHNOLOGY Dresden GmbH engages in the design, manufacture, and testing of electronic and electromechanical components, particularly miniaturized components. It specializes in technologies for the production of electronic circuit boards, installation of microassemblies, as well as the development and manufacture of equipment for the production and testing of microasseblies. The company was founded in November 1994 and is headquartered in Dresden, Germany. | Electronic Technology |
Nanotron Technologies GmbH
 Nanotron Technologies GmbH Telecommunications EquipmentElectronic Technology Nanotron Technologies GmbH develops and provides wireless communications systems. The firm’s platform consists of chips, modules, and software that enable real-time positioning and concurrent wireless communication. Its products include swarm, nano location systems (RTLS), and transceiver. The company was founded by Manfred Koslar and Zbigniew Ianelli in 1991 and is headquartered in Berlin, Germany. | Electronic Technology |
DirectPhotonics Industries GmbH
 DirectPhotonics Industries GmbH SemiconductorsElectronic Technology DirectPhotonics Industries GmbH develops, manufactures and sells diode laser systems. Its products are cutting and welding diodes, micro welding and optical pumping diodes, thermal processing, and direct original equipment manufactures. The company was founded on July 26, 2011 by Wolfgang Gries and Leif Alexandersson and is headquartered in Berlin, Germany. | Electronic Technology |
LemnaTec GmbH
LemnaTec GmbH Medical SpecialtiesHealth Technology LemnaTec GmbH develops research platforms and analysis software for agricultural chemistry, plant cultivation, biotechnology, and pharmacy. It generates reproducible and scientifically sound images in light wavelengths. The firm develops also imaging, image analysis automatisation, and data handling modules. The company was founded by Dirk Vandenhirtz and Matthias Eberius in 1998 and is headquartered in Aachen, Germany. | Health Technology |
DEWB Effecten GmbH
DEWB Effecten GmbH Financial ConglomeratesFinance Part of Deutsche Effecten & Wechsel Beteiligungs AG, DEWB Effecten GmbH operates as an investment holding German company. The company is based in Jena, Germany. The CEO of the company is Bertram Köhler. | Finance |
